To what extent are the antimalarial markets in African countries ready for a transition to triple artemisinin-based combination therapies?

par Freek de Haan, Oladimeji Akeem Bolarinwa, Rosemonde Guissou, Fatoumata Tou, Paulina Tindana, Wouter P C Boon, Ellen H M Moors, Phaik Yeong Cheah, Mehul Dhorda, Arjen M Dondorp, Jean Bosco Ouedraogo, Olugbenga A Mokuolu, Chanaki Amaratunga
Publié 2021